ALB and cancer: In this study of 557 NET patients treated with PRRT, examining inflammatory markers and prognostic scores previously associated with cancer outcomes, we showed that CRP and albumin‐based markers were independently associated with OS but could not detect an association for dNLR and other cellular inflammation‐based markers.